CLZR:a potential 10 bagger? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jay D. who wrote (36)	4/21/1997 8:54:00 AM
From: Bob Davis	of 315

Mark, The Dick Davis Digest (no relation to me) reprints stuff from other investment newsletters. Earlier this year they reprinted the following: "Candela (CLZR 5-5/8 OTC) is my top stock pick for 1997," says Ron Cram (Emerging Profit Letter, P.O. Box 245, Highland, CA 92345,12 issues, $59). "The company makes medical lasers and operates spas that offer cosmetic laser surgery. But I am most excited about its third operation - cryogenic surgery systems which kill cancer cells by liquid nitrogen. The American Urological Association recently declared that cryogenic surgery is no longer an investigative procedure, which opens the way for insurance reimbursement. It has $3 million in cash, $10.4 million in equity and a market cap of $32 million. Candela earned $0.09 per share in the last quarter on sales of $7.9 million. With cryogenic surgery reaching a wider market acceptance, we are projecting annual sales of $35 million and profits of $0.50 per share. Our 12-month target is 15." This is the specific quote. As you may know, I think that their $15.00 target is a bit unrealistic right now, but I suspect that it may be more realistic by the end of 1997. Bob Davis

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next